Oxelumab

Oxelumab^?

Monoclonal antibody
Type	Whole antibody
Source	Human
Target	OX-40 ligand
Clinical data
Identifiers
CAS Registry Number	1186098-83-8 N
ATC code	None
Chemical data
Formula	C6424H9920N1704O2014S42
Molecular mass	144.6 kDa
N (what is this?)  (verify)

Oxelumab is a human monoclonal antibody designed for the treatment of asthma.^[1]

Oxelumab was developed by Genentech and co-developed by Roche.

References

1. ↑ "Statement On A Nonproprietary Name Adopted By The USAN Council: Oxelumab" (PDF). American Medical Association.